Netherlands· NL-ed6e8ed1a72d

Temazepam Auro 10 mg, tabletten

A temazepam product containing temazepam, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N05CD07

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about temazepamAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Temazepam is registered in 9 of 19 countries.

Countries holding a registration under ATC N05CD07 (temazepam), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
4 of them publish a price we can compare per daily dose

Search temazepam products by name

Temazepam · ATC N05CD07

9 / 19 countries

Canada
Finlandprice
Germany
Ireland
Netherlands
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of temazepam costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Temazepam · price per daily dose (20 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.79
US United States$0.74 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TEMAZEPAM
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: N05CD07
ATC class: Temazepam
Defined daily dose: 20 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
14354

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

319 interactions on record for temazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check temazepam against other medicines How interaction checks work

Temazepam · interactions on record

319 records

4 severe
72 moderate
22 minor
218 info

Most severe, free to view

MorphineN02AA01severe
MorphinN07BC09severe
HydrocodoneR05DA03severe
CodeineR05DA04severe

3 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Temazepam in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All temazepam products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

Germany · Remestan, Remestan Mite
Finland · Tenox
United Kingdom (Northern Ireland) · Temazepam, Temazepam Generics [uk]
Hungary · Signopam
Ireland · Nortem
Malta · Temazepam Thame
Poland · Signopam, Teseda
Portugal · Normison

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/faaca41f-defc-4a71-862d-1e812cc9f39d
GET /v1/drugs/faaca41f-defc-4a71-862d-1e812cc9f39d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h14354_smpc.pdf",
  "strength": null,
  "atc_label": "Temazepam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg14354",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "LACTOSE 1-WATER",
    "MACROGOL 1500",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)"
  ],
  "substances": [
    "TEMAZEPAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h14354.pdf",
  "authorised_at": "1991/01/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "14354",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about temazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console